- Home
- Publications
- Publication Search
- Publication Details
Title
Iron overload in myelodysplastic syndromes (MDS)
Authors
Keywords
Myelodysplastic syndrome, Chronic transfusion therapy, Iron overload, Iron chelation, Deferasirox
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 107, Issue 1, Pages 55-63
Publisher
Springer Nature
Online
2017-11-25
DOI
10.1007/s12185-017-2367-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome – Emphasis on optimized dosing schedules and new formulations
- (2015) Florian Nolte et al. LEUKEMIA RESEARCH
- Effects of Iron Overload on the Bone Marrow Microenvironment in Mice
- (2015) Yuchen Zhang et al. PLoS One
- Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
- (2014) Ángel F. Remacha et al. ANNALS OF HEMATOLOGY
- Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis
- (2014) Philippe Armand et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
- (2014) Emanuele Angelucci et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The bone marrow hematopoietic microenvironment is impaired in iron-overloaded mice
- (2014) Hiroshi Okabe et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
- (2014) Michel Delforge et al. LEUKEMIA RESEARCH
- Atherogenesis and iron: from epidemiology to cellular level
- (2014) Francesca Vinchi et al. Frontiers in Pharmacology
- Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease
- (2013) M. Großekatthöfer et al. ANNALS OF HEMATOLOGY
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
- (2013) L. Malcovati et al. BLOOD
- Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients
- (2013) Laurent Pascal et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation
- (2013) Johanna M. Virtanen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cellsin vitroand suppresses hematopoiesis in iron overload patients
- (2013) Wenyi Lu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes
- (2013) Geane Felix de Souza et al. JOURNAL OF CLINICAL PATHOLOGY
- Oxidative Stress Levels in Myelodysplastic Syndrome Patients: Their Relationship to Serum Ferritin and Haemoglobin Values
- (2013) K Saigo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome
- (2013) Yang Jo Chung et al. LEUKEMIA RESEARCH
- Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload
- (2012) F. Nolte et al. ANNALS OF HEMATOLOGY
- Prognostic Impact of Posttransplantation Iron Overload after Allogeneic Stem Cell Transplantation
- (2012) Sara C. Meyer et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox
- (2012) Shohei Kikuchi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
- (2012) N. Gattermann et al. HAEMATOLOGICA
- Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome
- (2012) Alan F. List et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry
- (2012) Judith Neukirchen et al. LEUKEMIA RESEARCH
- Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes
- (2012) Julia Hartmann et al. LEUKEMIA RESEARCH
- Prognostic impact of iron parameters in patients undergoing allo-SCT
- (2011) G N Bazuave et al. BONE MARROW TRANSPLANTATION
- Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
- (2011) Noémi B. A. Roy et al. BRITISH JOURNAL OF HAEMATOLOGY
- On T2* Magnetic Resonance and Cardiac Iron
- (2011) John-Paul Carpenter et al. CIRCULATION
- Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)
- (2011) L. Malcovati et al. HAEMATOLOGICA
- The effect of iron overload and chelation on erythroid differentiation
- (2011) Kazuki Taoka et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox
- (2011) Florian Nolte et al. LEUKEMIA RESEARCH
- Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes
- (2011) Valeria Santini et al. PLoS One
- Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation
- (2010) Philippe Armand et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM
- (2010) Christian Rose et al. LEUKEMIA RESEARCH
- Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
- (2010) Norbert Gattermann et al. LEUKEMIA RESEARCH
- Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
- (2009) M. D. Cappellini et al. HAEMATOLOGICA
- Effect of deferasirox (ICL670) on arterial function in patients with beta-thalassaemia major
- (2008) Y. F. Cheung et al. BRITISH JOURNAL OF HAEMATOLOGY
- Oxidative DNA damage in bone marrow cells of patients with low-risk myelodysplastic syndrome
- (2008) Bozena Novotna et al. LEUKEMIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More